Organigram (TSE:OGI) Shares Down 3.6% – What’s Next?

Organigram Holdings Inc. (TSE:OGI) shares traded down 3.6% on Tuesday. The company traded as low as C$1.28 and last traded at C$1.32. 122,204 shares traded hands during trading, a decline of 38% from the average daily volume of 197,245 shares. The stock had previously closed at C$1.37.

Organigram Stock Performance

The firm has a market capitalization of C$190.28 million, a price-to-earnings ratio of 2.20, a P/E/G ratio of 0.42 and a beta of 1.64. The company has a 50-day moving average price of C$1.54 and a 200-day moving average price of C$1.57. The company has a quick ratio of 2.62, a current ratio of 2.61 and a debt-to-equity ratio of 6.48.

Organigram (TSE:OGI) last posted its earnings results on Tuesday, August 11th. The company reported C$0.77 EPS for the quarter. The firm had revenue of C$105.78 million for the quarter. Organigram had a return on equity of 21.99% and a net margin of 28.02%. As a group, equities research analysts forecast that Organigram Holdings Inc. will post 0.16 earnings per share for the current year.

Organigram Company Profile

Organigram Global Inc is listed on the NASDAQ Global Select Market and TSX. The Company’s wholly owned subsidiary, Organigram Inc, is a licensed cultivator and processor. Through its acquisition of Sanity Group GmbH (‘Sanity Group’), Organigram participates in the German medical cannabis market and other emerging markets within Europe. Organigram is focused on producing high-quality cannabis for adult consumers, as well as extending the Company’s global footprint. Organigram has also developed and acquired a portfolio of cannabis brands, including Edison, Big Bag O’ Buds, SHRED, Monjour, Tremblant, Collective Project, Trailblazer, BOXHOT and DEBUNK.